microdoses of glp 1 Microdosing GLP-1 Drugs: What To Know Is It Smart For You
Description
The first clinical study of an oral small-molecule GLP-1 receptor agonist suggests effective glycemic control and weight loss in patients with type 2 diabetes
Epub 2011 Feb 22
Lancet (2021) 397:97184
*Correspondence: Amancio Carnero [email protected] This article was submitted to Pharmacology of Anti-Cancer Drugs, a section of the journal Frontiers in Oncology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
These are some of the key questions well explore in this weeks newsletter
Weight regain is common if the medication is stopped without supportive measures
